Recombinant Human LAIR1 Fc Chimera Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 9964-LR

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
9964-LR-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

HEK293

Accession #

NP_002278

Structure / Form

Disulfide-linked homodimer

Conjugate

Unconjugated

Applications

Bioactivity

View all LAIR1 Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human LAIR1 protein
Human LAIR1
(Gln22-His163)
Accession # NP_002278		 IEGRMD Human IgG1
(Pro100-Lys330)
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

No results obtained. Gln22 inferred from enzymatic pyroglutamate treatment revealing Glu23.

Predicted Molecular Mass

42 kDa

SDS-PAGE

55-65 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Bovine Collagen I is coated at 10 µg/mL, 100 μL/well, Recombinant Human LAIR1 Fc Chimera binds with an ED50 of 25-150 ng/mL.

Reviewed Applications

Read 1 review rated 4 using 9964-LR in the following applications:

Scientific Data Images for Recombinant Human LAIR1 Fc Chimera Protein, CF

Recombinant Human LAIR1 Fc Chimera Protein Binding Activity

Recombinant Human LAIR1 Fc Chimera Protein Binding Activity

When Bovine Collagen I is coated at 10 µg/mL, Recombinant Human LAIR-1 Fc Chimera binds with an ED50 of 25-150 ng/mL.
Recombinant Human LAIR1 Fc Chimera Protein SDS-PAGE

Recombinant Human LAIR1 Fc Chimera Protein SDS-PAGE

2 μg/lane of Recombinant Human LAIR1 was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® blue staining, showing bands at 55-65 kDa and 110-130 kDa, respectively.

Formulation, Preparation and Storage

9964-LR
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 500 μg/mL in PBS.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
  • 12 months from date of receipt, ≤ -20 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, ≤ -20 °C under sterile conditions after reconstitution.

Background: LAIR1

LAIR1 (leukocyte-associated Ig-like receptor-1, designated CD305) is an approximately 40 kDa type I transmembrane inhibitory glycoprotein belonging to the Ig superfamily (1-4). LAIR1 is a collagen-binding protein that is expressed in a differentiation- and activation-dependent manner on most immune cells, including T, B, NK and dendritic cells (DC), monocytes, CD34+ hematopoietic progenitors, most thymocytes, and selected granulocyte populations (2-7). Mature human LAIR1 is a 266 amino acid (aa) type I transmembrane protein that includes a 144 aa extracellular domain (ECD) with one collagen-binding C2-type Ig-like domain, and a 101 aa cytoplasmic domain with two ITIM motifs (2, 3, 8, 9). Of four potential human LAIR1 splice variants, LAIR1b has a 17 aa deletion within the ECD, but outside the Ig domain. LAIR1c differs from LAIR1b by one aa. LAIR1d has a 78 aa cytoplasmic truncation and lacks ITIM motifs. Human LAIR1 ECD shares <45% aa sequence identity with mouse, rat, bovine or canine LAIR1 ECD, but all are functional orthologs. Humans, but not rodents, also express the 152 aa secreted protein LAIR2, which shares 83% aa sequence identity with the LAIR1 ECD up to aa 140 and can block LAIR1 collagen binding (1, 2). A soluble form of LAIR1 found in plasma and urine also binds collagen (10). Adhesion of LAIR1 to collagens in the extracellular matrix, transmembrane collagens expressed by tumor cells, or antibody-mediated crosslinking of LAIR1, inhibits signals relayed by ITAM-bearing receptors and some cytokine-mediated signals (6-8, 13). Processes that are inhibited include B and T cell receptor-mediated activation, NK and T cell‑mediated cytotoxicity, and basophil degranulation (1-4, 8). LAIR1 is reduced or absent on chronic lymphocytic leukemia (CLL) B cells, and some B and DC cells in systemic lupus erythematosus (SLE). Its under‑expression potentially enhances CLL proliferation and SLE immune responses (7, 11, 12).

References

  1. Meyaard, L. (2008) J. Leukoc. Biol. 83:799.
  2. Meyaard, L. et al. (1997) Immunity 7:283.
  3. Lebbink, R.J. et al. (2004) J. Immunol. 172:5535.
  4. Ouyang, W. et al. (2003) Biochem. Biophys. Res. Commun. 310:1236.
  5. Verbrugge, A. et al. (2006) J. Leukoc. Biol. 79:828.
  6. Lebbink, R.J. et al. (2006) J. Exp. Med. 203:1419.
  7. Bonaccorsi, I. et al. (2010) PLoS ONE 5:e15080.
  8. Tang, X. et al. (2009) J. Immunol. 182:5446.
  9. Brondijk, T.H.C. et al. (2010) Blood 115:1364.
  10. Olde Nordkamp, M.J. et al. (2011) Arthritis Rheum. 63:3749.
  11. Poggi, A. et al. (2008) Leukemia 22:980.
  12. Colombo, B.M. et al. (2012) PLoS ONE 7:e31903.
  13. Rygiel, T.P. et al. (2011) Mol. Immunol. 49(1-2):402.

Long Name

Leukocyte-associated Ig-like Receptor 1

Alternate Names

CD305, HLAIR1, LAIR-1

Entrez Gene IDs

3903 (Human); 52855 (Mouse); 574531 (Rat); 102136964 (Cynomolgus Monkey)

Gene Symbol

LAIR1

UniProt

NP_002278

Additional LAIR1 Products

Product Documents for Recombinant Human LAIR1 Fc Chimera Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human LAIR1 Fc Chimera Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.